Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce D Walker

Showing results (181-190 of 490) with videos related to

Pageof 49
Sort By:
Plos One|March 18, 2015
High frequency of transmitted HIV-1 Gag HLA class I-driven immune escape variants but minimal immune selection over the first year of clade C infectionKamini Gounder, Nagavelli Padayachi, Jaclyn K Mann, et al.
Journal of Virology|October 31, 2008
HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1Toshiyuki Miura, Mark A Brockman, Zabrina L Brumme, et al.
AIDS (London, England)|December 23, 2008
Epidemiologically linked transmission of HIV-1 illustrates the impact of host genetics on virological outcomeHendrik Streeck, Heiko Jessen, Claudia Kuecherer, et al.
Journal of Immunological Methods|December 23, 2008
A method for identification of HIV gp140 binding memory B cells in human bloodJohannes F Scheid, Hugo Mouquet, Niklas Feldhahn, et al.
Journal of Virology|January 21, 2009
HLA-associated viral mutations are common in human immunodeficiency virus type 1 elite controllersToshiyuki Miura, Chanson J Brumme, Mark A Brockman, et al.
Plos One|October 15, 2013
Non-immunogenicity of overlapping gag peptides pulsed on autologous cells after vaccination of HIV infected individualsHenrik N Kløverpris, Akil Jackson, Amanda Handley, et al.
The Journal of Infectious Diseases|March 9, 2016
Lower Viral Loads and Slower CD4+ T-Cell Count Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B*58:02Ellen M Leitman, Jacob Hurst, Masahiko Mori, et al.
Plos One|April 6, 2012
Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic HIV-1 gag vaccine trialJonathan Z Li, Chanson J Brumme, Michael M Lederman, et al.
AIDS Research and Human Retroviruses|September 10, 2013
HIV subtype influences HLA-B*07:02-associated HIV disease outcomeHenrik N Kløverpris, Emily Adland, Madoka Koyanagi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
Motif inference reveals optimal CTL epitopes presented by HLA class I alleles highly prevalent in southern AfricaIsobella Honeyborne, Almas Rathod, Rico Buchli, et al.
Pageof 49

Showing results (181-190 of 490) with videos related to

Sort By:
Pageof 49
Plos One|March 18, 2015
High frequency of transmitted HIV-1 Gag HLA class I-driven immune escape variants but minimal immune selection over the first year of clade C infectionKamini Gounder, Nagavelli Padayachi, Jaclyn K Mann, et al.
Journal of Virology|October 31, 2008
HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1Toshiyuki Miura, Mark A Brockman, Zabrina L Brumme, et al.
AIDS (London, England)|December 23, 2008
Epidemiologically linked transmission of HIV-1 illustrates the impact of host genetics on virological outcomeHendrik Streeck, Heiko Jessen, Claudia Kuecherer, et al.
Journal of Immunological Methods|December 23, 2008
A method for identification of HIV gp140 binding memory B cells in human bloodJohannes F Scheid, Hugo Mouquet, Niklas Feldhahn, et al.
Journal of Virology|January 21, 2009
HLA-associated viral mutations are common in human immunodeficiency virus type 1 elite controllersToshiyuki Miura, Chanson J Brumme, Mark A Brockman, et al.
Plos One|October 15, 2013
Non-immunogenicity of overlapping gag peptides pulsed on autologous cells after vaccination of HIV infected individualsHenrik N Kløverpris, Akil Jackson, Amanda Handley, et al.
The Journal of Infectious Diseases|March 9, 2016
Lower Viral Loads and Slower CD4+ T-Cell Count Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B*58:02Ellen M Leitman, Jacob Hurst, Masahiko Mori, et al.
Plos One|April 6, 2012
Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic HIV-1 gag vaccine trialJonathan Z Li, Chanson J Brumme, Michael M Lederman, et al.
AIDS Research and Human Retroviruses|September 10, 2013
HIV subtype influences HLA-B*07:02-associated HIV disease outcomeHenrik N Kløverpris, Emily Adland, Madoka Koyanagi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
Motif inference reveals optimal CTL epitopes presented by HLA class I alleles highly prevalent in southern AfricaIsobella Honeyborne, Almas Rathod, Rico Buchli, et al.
Pageof 49